Results 231 to 240 of about 1,158,241 (286)
Some of the next articles are maybe not open access.

The overprediction of fear and panic in panic disorder

Behaviour Research and Therapy, 1994
The present study examined changes in the prediction of fear and panic in a clinical sample of patients (N = 25) meeting DSM-III-R criteria for panic disorder with agoraphobia (PDA). Data were collected for approx. 2000 trials of in vivo exposure. As expected, PDA patients displayed a bias for overpredicting both the level of fear and the likelihood of
N B, Schmidt, K, Jacquin, M J, Telch
openaire   +2 more sources

Panic and panic disorder in the United States

American Journal of Psychiatry, 1994
The goal of this study was to determine the prevalence of DSM-III-R panic disorder and to describe its correlates.The study was part of the National Comorbidity Survey, the first psychiatric epidemiologic survey of the entire U.S. population and the first to use DSM-III-R criteria for diagnosis.
W W, Eaton   +3 more
openaire   +2 more sources

Psychopathology of panic attacks in panic disorder

Journal of Affective Disorders, 2006
This study examined the relationships among certain subtypes of panic attacks (full vs. limited symptom; spontaneous vs. situational) and between these subtypes, panic disorder subtypes, and other characteristics of panic disorder, especially agoraphobia.Data were drawn from a large (n = 1,168) treatment study of panic disorder in which panic attacks ...
E H, Uhlenhuth   +2 more
openaire   +2 more sources

Seasonality in panic disorder

Journal of Affective Disorders, 1994
Following a clinical observation of increased anxiety symptoms and mood changes during winter in panic disorder patients, the Seasonal Pattern Assessment Questionnaire (SPAQ) was completed by 133 patients. Global Seasonality Scores (GSS), and the prevalence of Seasonal Affective Disorder (SAD), were significantly higher than reported in general ...
Marriott, P F   +2 more
openaire   +3 more sources

Hyperventilation and panic disorder

The American Journal of Medicine, 1987
Hyperventilation syndrome and panic disorder are both common, serious, and easily treatable disorders. The similarity of their symptoms and physiology, the demonstration of hyperventilation during spontaneous and laboratory-induced panic episodes, provocation of panic-like symptoms in some patients with panic disorder using hyperventilation, the ...
D S, Cowley, P P, Roy-Byrne
openaire   +2 more sources

Fluoxetine in Panic Disorder

The Canadian Journal of Psychiatry, 1991
This paper presents the cases of two patients who suffered from panic disorder with agoraphobia and depression. One had been refractory to alprazolam and tricyclics and to behaviour therapy; she had responded to phenelzine, but due to a weight gain of 50 lbs, had discontinued treatment and she relapsed.
L, Solyom, C, Solyom, B, Ledwidge
openaire   +2 more sources

Cholecystokinin and panic disorder

Acta Neuropsychiatrica, 2004
Evidence for implication of cholecystokinin (CCK) in the neurobiology of panic disorder is reviewed through animal and human pharmacological studies. The results of these investigations raise two issues: (i) selectivity of action of CCK-2 agonists in anxiety disorders; and (ii) aberrations of the CCK system in anxiety disorders, both of which are ...
Michel, Bourin, Eric, Dailly
openaire   +2 more sources

Epidemiology of Panic Disorder

Human Psychopharmacology: Clinical and Experimental, 1997
The prevalence of panic disorder in the general population is 2,3% over a person's whole life, and 0,5-1% per year. International studies have yielded more widely varying estimates of the prevalence of panic attacks (4-12%). The proportion of patients consulting their doctors for panic disorder is also highly variable; the frequency is a function of ...
openaire   +2 more sources

Fluoxetine in Panic Disorder

Journal of Clinical Psychopharmacology, 1990
Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 months. For most patients, treatment was initiated at 5 mg/day to minimize adverse effects previously reported with initiation at higher doses.
F R, Schneier   +6 more
openaire   +2 more sources

The genetics of panic disorder

Current Psychiatry Reports, 2001
Of the anxiety disorders, panic disorder (PD) has been the most extensively studied from a genetic standpoint. Results of family studies have consistently demonstrated that PD runs in families, and twin studies indicate that genes contribute to this familiality.
C T, Finn, J W, Smoller
openaire   +2 more sources

Home - About - Disclaimer - Privacy